LENZ THERAPEUTICS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LENZ THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $14.00K, a 68.18% decline year-over-year.
- LENZ THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $598.00K, a 949.12% increase year-over-year.
- LENZ THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $196.00K, a 94.26% decline year-over-year.
- LENZ THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $44.00K, a 340.00% increase year-over-year.
- LENZ THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $1.12M.
- LENZ THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $100.00K, a 400.00% increase from fiscal 2022.
- LENZ THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $20.00K, a 52.38% decline from fiscal 2021.
- LENZ THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $42.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-03-31 | $14.00K 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $1.12M 10-K · filed 2026-03-24 | |
| 2025-09-30 | $598.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $196.00K 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $44.00K 10-Q · filed 2026-08-11 | |
| 2024-09-30 | $57.00K 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $3.41M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $10.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $100.00K 10-K · filed 2024-02-27 | |
| 2023-09-30 | $16.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $18.00K 10-Q · filed 2023-11-13 | |
| 2023-03-31 | $19.00K 10-Q · filed 2024-05-08 | |
| 2022-12-31 | $20.00K 10-K · filed 2024-02-27 | |
| 2022-09-30 | $5.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $13.00K 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $42.00K 10-K · filed 2023-03-20 | |
| 2021-06-30 | $21.00K 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |